東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Live attenuated vaccines against avi...

Patnayak, Devi Prasanna.

FindBook

Google Book

Amazon

博客來

Live attenuated vaccines against avian pneumovirus.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Live attenuated vaccines against avian pneumovirus./
作者:	Patnayak, Devi Prasanna.
面頁冊數:	154 p.
附註:	Source: Dissertation Abstracts International, Volume: 67-06, Section: B, page: 3001.
Contained By:	Dissertation Abstracts International67-06B.
標題:	Biology, Animal Physiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3220023
ISBN:	9780542735264

Live attenuated vaccines against avian pneumovirus.
Patnayak, Devi Prasanna.

Live attenuated vaccines against avian pneumovirus. - 154 p.

Source: Dissertation Abstracts International, Volume: 67-06, Section: B, page: 3001.

Thesis (Ph.D.)--University of Minnesota, 2006.

Avian pneumovirus (APV) is increasingly recognized as an important respiratory pathogen of turkeys causing a rapidly spreading disease of all ages. Because of the significant economic impact of the disease, there has been an urgent and critical need to develop effective vaccines and vaccination strategies against APV strains prevalent in the United States. Researchers in the U.S. initially worked on the development of killed vaccines but because of their low efficacy, efforts have now been devoted to the development of live, attenuated vaccines. Earlier, our laboratory reported on the development of an attenuated vaccine by passaging a local isolate (APV/MN-1a) in vitro for 41 passages (named P41). Because of its residual pathogenicity, despite being protective, we further passaged this strain for an additional 22 passages and named it as P63. In the present work, safety and efficacy of this attenuated virus was evaluated. In another approach, cold adaptation was undertaken for developing another live vaccine. Both vaccines were evaluated for their efficacy in turkeys following administration by different routes of inoculation. The duration of immunity with both vaccines was also studied and efforts were made to evaluate possibilities of increasing titers of these vaccines in cell cultures.

ISBN: 9780542735264Subjects--Topical Terms:

1017835
Biology, Animal Physiology.

Live attenuated vaccines against avian pneumovirus.
LDR:03098nmm 2200289 4500 001 1828938
005 20071023113056.5
008 130610s2006 eng d
020 $a 9780542735264
035 $a (UMI)AAI3220023
035 $a AAI3220023
040 $a UMI $c UMI
100 1 $a Patnayak, Devi Prasanna. $3 1917814
245 1 0 $a Live attenuated vaccines against avian pneumovirus.
300 $a 154 p.
500 $a Source: Dissertation Abstracts International, Volume: 67-06, Section: B, page: 3001.
500 $a Adviser: Sagar M. Goyal.
502 $a Thesis (Ph.D.)--University of Minnesota, 2006.
520 $a Avian pneumovirus (APV) is increasingly recognized as an important respiratory pathogen of turkeys causing a rapidly spreading disease of all ages. Because of the significant economic impact of the disease, there has been an urgent and critical need to develop effective vaccines and vaccination strategies against APV strains prevalent in the United States. Researchers in the U.S. initially worked on the development of killed vaccines but because of their low efficacy, efforts have now been devoted to the development of live, attenuated vaccines. Earlier, our laboratory reported on the development of an attenuated vaccine by passaging a local isolate (APV/MN-1a) in vitro for 41 passages (named P41). Because of its residual pathogenicity, despite being protective, we further passaged this strain for an additional 22 passages and named it as P63. In the present work, safety and efficacy of this attenuated virus was evaluated. In another approach, cold adaptation was undertaken for developing another live vaccine. Both vaccines were evaluated for their efficacy in turkeys following administration by different routes of inoculation. The duration of immunity with both vaccines was also studied and efforts were made to evaluate possibilities of increasing titers of these vaccines in cell cultures.
520 $a The results of experimental evaluation indicated that both vaccines were protective in 4-week old turkeys at two different doses. No reversion to virulence was observed when P63 was passaged six successive times in vivo. It was found to be protective following aerosol, oculo-nasal and oral routes of inoculation. The cold adapted vaccine was administered at 1 day of age by all three routes. Although the vaccine was found to be protective, it did produce mild clinical signs in some birds following vaccination. Both vaccines conferred protection for up to 14 weeks post vaccination following administration of a single dose. In another study, both vaccine strains grew to high titers in BGM-70 cells in addition to commonly used Vero cells. Since vaccination is the major method in the control of APV, efforts should continue to improve the current vaccines and to develop newer, more effective vaccines.
590 $a School code: 0130.
650 4 $a Biology, Animal Physiology. $3 1017835
650 4 $a Biology, Veterinary Science. $3 1021733
690 $a 0433
690 $a 0778
710 2 0 $a University of Minnesota. $3 676231
773 0 $t Dissertation Abstracts International $g 67-06B.
790 1 0 $a Goyal, Sagar M., $e advisor
790 $a 0130
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3220023